Moreover, further understanding of the participation of immune mediators, such as the chemokines RANTES/CCL5 and IP10, in the trophoblast response to ZIKV infection may open a path for drug development or repurposing to possibly inhibit viral replication or avoid viral dissemination into fetus’ tissues. Here, CCL5 is linked to Zika virus infectious disease.